Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qing Han

Showing results (741-750 of 760) with videos related to

Pageof 76
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Stephen E Webber, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Database : the Journal of Biological Databases and Curation|February 3, 2023
Automatic Extraction of Medication Mentions from Tweets-Overview of the BioCreative VII Shared Task 3 CompetitionDavy Weissenbacher, Karen O'Connor, Siddharth Rawal, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|February 10, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymeraseFrank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Journal of Medical Genetics|September 21, 2021
Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland populationYong-Ping Chen, Shi-Hui Yu, Qian-Qian Wei, et al.
Emerging Microbes & Infections|November 10, 2021
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in ChinaXiaoqing Liu, Lifan Zhang, Fengchun Zhang, et al.
Emotion (Washington, D.C.)|March 13, 2023
Pandemic boredom: Little evidence that lockdown-related boredom affects risky public health behaviors across 116 countriesErin C Westgate, Nicholas R Buttrick, Yijun Lin, et al.
Pageof 76

Showing results (741-750 of 760) with videos related to

Sort By:
Pageof 76
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Stephen E Webber, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Database : the Journal of Biological Databases and Curation|February 3, 2023
Automatic Extraction of Medication Mentions from Tweets-Overview of the BioCreative VII Shared Task 3 CompetitionDavy Weissenbacher, Karen O'Connor, Siddharth Rawal, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|February 10, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymeraseFrank Ruebsam, Douglas E Murphy, Chinh V Tran, et al.
Journal of Medical Genetics|September 21, 2021
Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland populationYong-Ping Chen, Shi-Hui Yu, Qian-Qian Wei, et al.
Emerging Microbes & Infections|November 10, 2021
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in ChinaXiaoqing Liu, Lifan Zhang, Fengchun Zhang, et al.
Emotion (Washington, D.C.)|March 13, 2023
Pandemic boredom: Little evidence that lockdown-related boredom affects risky public health behaviors across 116 countriesErin C Westgate, Nicholas R Buttrick, Yijun Lin, et al.
Pageof 76